Today The Cornercap Investment Counsel Inc. Has $609,000 Stake in Kindred Healthcare, Inc. (KND)

Today The Cornercap Investment Counsel Inc. Has $609,000 Stake in Kindred Healthcare, Inc. (KND)

Cornercap Investment Counsel Inc. reduced its position in Kindred Healthcare, Inc. (NYSE:KND) by 1.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 77,580 shares of the company’s stock after selling 995 shares during the period. Cornercap Investment Counsel Inc. owned approximately 0.09% of Kindred Healthcare worth $609,000 as of its most recent filing with the SEC.

Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in Kindred Healthcare by 1.5% in the second quarter. Vanguard Group Inc. now owns 6,661,260 shares of the company’s stock valued at $75,207,000 after buying an additional 97,330 shares during the period. BlackRock Fund Advisors boosted its position in shares of Kindred Healthcare by 8.2% in the third quarter. BlackRock Fund Advisors now owns 6,465,561 shares of the company’s stock valued at $66,078,000 after buying an additional 489,417 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Kindred Healthcare by 1.6% in the second quarter. Dimensional Fund Advisors LP now owns 6,363,481 shares of the company’s stock valued at $71,844,000 after buying an additional 101,726 shares during the period. LSV Asset Management boosted its position in shares of Kindred Healthcare by 5.1% in the third quarter. LSV Asset Management now owns 4,345,805 shares of the company’s stock valued at $44,414,000 after buying an additional 212,500 shares during the period. Finally, State Street Corp boosted its position in shares of Kindred Healthcare by 6.7% in the second quarter. State Street Corp now owns 2,262,885 shares of the company’s stock valued at $25,549,000 after buying an additional 141,988 shares during the period. Hedge funds and other institutional investors own 97.13% of the company’s stock.

Shares of Kindred Healthcare, Inc. (NYSE:KND) remained flat at $7.35 on Wednesday. 264,058 shares of the company’s stock traded hands. Kindred Healthcare, Inc. has a 12-month low of $5.65 and a 12-month high of $15.66. The firm’s market capitalization is $625.93 million. The firm has a 50 day moving average price of $7.76 and a 200 day moving average price of $9.38.

Kindred Healthcare (NYSE:KND) last announced its quarterly earnings data on Monday, November 7th. The company reported $0.05 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.06 by $0.01. Kindred Healthcare had a positive return on equity of 5.78% and a negative net margin of 8.31%. The firm had revenue of $1.79 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same period in the previous year, the business posted $0.23 EPS. Kindred Healthcare’s revenue for the quarter was up 1.6% compared to the same quarter last year. Equities research analysts forecast that Kindred Healthcare, Inc. will post $0.74 EPS for the current fiscal year.

Several equities analysts recently issued reports on KND shares. Barclays PLC restated a “buy” rating and set a $17.00 price objective on shares of Kindred Healthcare in a research note on Tuesday, November 8th. Zacks Investment Research upgraded Kindred Healthcare from a “sell” rating to a “buy” rating and set a $9.00 price objective on the stock in a research note on Wednesday, January 11th. RBC Capital Markets restated a “hold” rating and set a $9.00 price objective on shares of Kindred Healthcare in a research note on Tuesday, January 3rd. J P Morgan Chase & Co restated a “hold” rating and set a $11.00 price objective on shares of Kindred Healthcare in a research note on Thursday, November 10th. Finally, Mizuho reduced their price objective on Kindred Healthcare from $11.00 to $7.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 8th. Four research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $10.22.

About Kindred Healthcare

Kindred Healthcare, Inc is a healthcare services company. The Company operates through four divisions, including the hospital division, the Kindred at Home division, the Kindred Rehabilitation Services division and the nursing center division. Its divisions represent over six segments, including hospitals, home health services, hospice services, Kindred Hospital Rehabilitation Services, RehabCare and nursing centers.

Want to see what other hedge funds are holding KND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kindred Healthcare, Inc. (NYSE:KND).

Related posts

Leave a Comment